Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the ...

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as ...

The Breast Cancer market is undergoing significant expansion, driven by increasing disease prevalence and the introduction of innovative therapeutic options from companies such as ...

There are other top blue-chip ETFs to buy when the trade war starts. The most notable ones are the Schwab US Dividend Equity ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Fearing potential tariffs from President Trump's announcement, some European drugmakers are increasing air shipments of ...

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its investigational obesity drug, VK2735, as the biotech positions itself to ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

PT: Why do you think Eli Lilly is coming out as a social media ... focused on six countries [US, Germany, France, Italy, UK and Japan]. The communities are smaller here, deliberately so ...

Some drugmakers are taking the unusual step of sending more medicines by air to the U.S., two executives and two logistics ...

Eli Lilly is already a big name in the Alzheimer’s disease space ... The global Alzheimer’s disease market across the eight ...